Connect Biopharma Holdings Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Connect Biopharma Holdings Limited's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every $100 of net worth, $100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 96% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 89% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-96.9×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 81% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Less steady than 51% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-159.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 89% of Healthcare companies in United States.
Cash Cushion Ratio
+91%Cash, after subtracting all debt, equals 91% of its market value (net cash).
Higher than 86% of Healthcare companies in United States.
Tangible Assets Ratio
100%Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 96% of Healthcare companies in United States.
Tangible Net Worth Ratio
100%Of every $100 of net worth, $100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 96% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Connect Biopharma Holdings Limited made a loss over the last year. Connect Biopharma Holdings Limited owes $0.38 for every $1 it owns. Connect Biopharma Holdings Limited made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossConnect Biopharma Holdings Limited made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.79The share price is 1.79 times Connect Biopharma Holdings Limited's book value per share, lower than 62% of Healthcare companies in United States.
Market cap
$48 MThe total market value of all of Connect Biopharma Holdings Limited's shares at today's price (share price × number of shares), smaller than 74% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$27 MWhat Connect Biopharma Holdings Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.43Net worth divided by the number of shares. The share price of $0.76 is 1.8 times this, which is the P/B above.
Return on equity (ROE)
-140.5%Connect Biopharma Holdings Limited lost 140.5% of its shareholders' money over the last year, lower than 79% of Healthcare companies in United States.
Owes vs Owns
0.38×Connect Biopharma Holdings Limited owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Dividend yield
NoneConnect Biopharma Holdings Limited does not currently pay a dividend.
Revenue growth
-100%Revenue fell 100% in the year to Dec 2025.
Profit growth
LossConnect Biopharma Holdings Limited made a loss in each of the last two years.
Profit margin
-86687.5%Connect Biopharma Holdings Limited lost $86688 for every $100 of revenue.
Cash vs debt
Net cashConnect Biopharma Holdings Limited held $44 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Connect Biopharma Holdings Limited: $48 M ÷ $27 M (30 Jun 2026) = 1.8.
What is Connect Biopharma Holdings Limited's return on equity?
Connect Biopharma Holdings Limited lost 140.5% of its shareholders' money over the last year, lower than 79% of Healthcare companies in United States.
How much does Connect Biopharma Holdings Limited owe compared with what it owns?
Connect Biopharma Holdings Limited owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Does Connect Biopharma Holdings Limited pay a dividend?
No. Connect Biopharma Holdings Limited does not currently pay a dividend.
Is Connect Biopharma Holdings Limited's revenue growing?
Revenue fell 100% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.